NasdaqGM:TMDXMedical Equipment
Assessing TransMedics Group (TMDX) Valuation As Its Organ Care System And Service Model Gain Momentum
TransMedics Group (TMDX) is in focus after its Organ Care System gained broader traction, supported by multiple FDA approvals, a shift toward a recurring full service model and plans for kidney and international market expansion.
See our latest analysis for TransMedics Group.
Despite the recent 7 day share price return of a 6.74% decline and a softer 30 day move, TransMedics Group’s 1 year total shareholder return of 76.33% and 5 year total shareholder return of 332.72% point to strong longer...